Back to top
more

Nu Skin Enterprises (NUS)

(Real Time Quote from BATS)

$12.44 USD

12.44
240,568

-0.50 (-3.86%)

Updated Jun 14, 2024 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 24% (190 out of 249)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Nu Skin Boasts Customer Growth, Faces Weak Gross Margin

by Zacks Equity Research

Nu Skin (NUS) gains from an expanding customer base and prudent product launches. However, persistent decline in gross margin is a concern.

Estee Lauder's Buyouts & Robust Online Business Bode Well

by Zacks Equity Research

Estee Lauder's (EL) solid focus on buyouts, travel retail network, effective launches and strong online sales are impressive.

NUS vs. IPAR: Which Stock Is the Better Value Option?

by Zacks Equity Research

NUS vs. IPAR: Which Stock Is the Better Value Option?

Nabaparna Bhattacharya headshot

Can Value Investors Consider Nu Skin (NUS) Stock Now?

by Nabaparna Bhattacharya

Nu Skin (NUS) stock may be a good choice for value-oriented investors right now from multiple angles.

Zacks.com featured highlights include: Materion, Boston Beer , Nu Skin, Darden and Comfort Systems

by Zacks Equity Research

Zacks.com featured highlights include: Materion, Boston Beer , Nu Skin, Darden and Comfort Systems

Coty Picks Up Steam, Stock Rallies 59% Since Q2 Results

by Zacks Equity Research

Coty's (COTY) Luxury unit continues to deliver a strong show. Also, acquisitions and e-commerce efforts bode well amid hurdles like soft Consumer Beauty segment.

Will Strong Demand Fuel United Natural's (UNFI) Q2 Earnings

by Zacks Equity Research

United Natural's (UNFI) Q2 results to gain from robust demand conditions and buyouts. However, rising fright costs and unfavorable consumer mix are concerns.

Sanghamitra Saha headshot

What Bargain Hunting? Bet on 5 Stocks With Rising P/E

by Sanghamitra Saha

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

British American (BTI) 2018 Earnings: Pricing a Key Catalyst

by Zacks Equity Research

British American's (BTI) preliminary 2018 results to gain from robust pricing as well as growth in low-risk tobacco products.

Factors Setting the Tone for FEMSA (FMX) in Q4 Earnings

by Zacks Equity Research

FEMSA's (FMX) fourth-quarter 2018 results might be hurt by higher operating expenses. However, its strategic actions to boost growth remain encouraging.

Estee Lauder Hits 52-Week High: What's Behind the Rally?

by Zacks Equity Research

Estee Lauder (EL) gains from a solid focus on buyouts, travel retail network, effective launches and strong online sales.

Zacks.com featured highlights include: Ralph Lauren, Nu Skin, Tilly's, Centene and STAAR

by Zacks Equity Research

Zacks.com featured highlights include: Ralph Lauren, Nu Skin, Tilly's, Centene and STAAR

Here's Why Estee Lauder (EL) Looks Lucrative Post Q2 Earnings

by Zacks Equity Research

Estee Lauder (EL) has been gaining on buyouts, strong travel retail network and sturdy online sales. These factors drove Q2 results, which was followed by a raised outlook.

Sanghamitra Saha headshot

Ride on Rising P/E Investing With These 5 Top-Ranked Stocks

by Sanghamitra Saha

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Avon (AVP) Stock Down on Q4 Earnings and Revenues Miss

by Zacks Equity Research

Avon (AVP) posts dismal fourth-quarter 2018 results. Further, it witnesses a decline in both its Active and Ending Representatives.

NUS vs. EL: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

NUS vs. EL: Which Stock Is the Better Value Option?

Nu Skin (NUS) Q4 Earnings Surpass Estimates, Decrease Y/Y

by Zacks Equity Research

Nu Skin (NUS) delivers better-than-expected fourth-quarter 2018 results, wherein the top line improves year over year on solid performances across most regional segments.

Nu Skin Enterprises (NUS) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Nu Skin (NUS) delivered earnings and revenue surprises of 1.94% and 1.48%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Will Currency be a Drag on Nu Skin's (NUS) Q4 Earnings?

by Zacks Equity Research

Nu Skin's (NUS) Q4 results to be hurt by weak gross margin and unfavorable currency translations. Nevertheless, expanding customer base and sales leaders are likely to offer respite.

Earnings Preview: Nu Skin Enterprises (NUS) Q4 Earnings Expected to Decline

by Zacks Equity Research

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Nu Skin's Sales Leaders & Customers Revive Lost Sheen?

by Zacks Equity Research

Nu Skin (NUS) grapples with sluggish gross margin and adverse currency trends. Nevertheless, strength in sales leaders and customers are encouraging.

Can Growth in Sales Leaders Uplift Nu Skin Stock in 2019?

by Zacks Equity Research

Nu Skin (NUS) is reeling under soft margins and adverse impacts from currency fluctuations. However, sturdy base of sales leaders and customers is likely to enhance performance.

Why Is Nu Skin (NUS) Up 1.5% Since Last Earnings Report?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Moving Average Crossover Alert: Nu Skin Enterprises (NUS)

by Zacks Equity Research

Nu Skin Enterprises (NUS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

Nu Skin (NUS) Stock Down on Q3 Earnings Miss, Sales Rise Y/Y

by Zacks Equity Research

Negative currency translation weighs on Nu Skin's (NUS) Q3 performance. Nevertheless, sales leaders and customer count continues to rise.